Southern Financial Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2140714 BIRMINGHAM, AL

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$270,746

-$26,390 QoQ

Shares Held

2,143

+0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#1,729

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Southern Financial Group, LLC holds $2,677,561 across 6 Drug Manufacturers - General names. GILD ranks #5 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	3,148	$792,162
2	PFE	Pfizer Inc	21,665	$521,693
3	BMY	Bristol Myers Squibb Co	8,834	$509,015
4	MRK	Merck & Co., Inc.	2,560	$328,960
5	GILD	Gilead Sciences, Inc. This page	2,143	$270,746
6	JNJ	Johnson & Johnson	1,004	$254,985

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$270,746	2,143	+0.5%	Shares	Sole	2026-07-24
2026-03-31	$297,136	2,132	+0.6%	Shares	Sole	2026-06-18
2025-12-31	$260,208	2,120	—	Shares	Sole	2026-06-18
No filing history on record for this holder in this stock.